SCYNEXIS Inc (SCYX)
1.42
+0.02
(+1.43%)
USD |
NASDAQ |
Apr 19, 12:23
SCYNEXIS Market Cap: 53.61M for April 19, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 18, 2024 | 52.85M |
| April 17, 2024 | 53.61M |
| April 16, 2024 | 53.23M |
| April 15, 2024 | 55.50M |
| April 12, 2024 | 54.55M |
| April 11, 2024 | 60.41M |
| April 10, 2024 | 59.65M |
| April 09, 2024 | 61.54M |
| April 08, 2024 | 61.54M |
| April 05, 2024 | 64.56M |
| April 04, 2024 | 63.43M |
| April 03, 2024 | 67.96M |
| April 02, 2024 | 54.74M |
| April 01, 2024 | 56.25M |
| March 28, 2024 | 55.50M |
| March 27, 2024 | 53.80M |
| March 26, 2024 | 52.48M |
| March 25, 2024 | 53.99M |
| March 22, 2024 | 52.48M |
| March 21, 2024 | 52.85M |
| March 20, 2024 | 53.23M |
| March 19, 2024 | 54.36M |
| March 18, 2024 | 54.36M |
| March 15, 2024 | 54.74M |
| March 14, 2024 | 56.63M |
| Date | Value |
|---|---|
| March 13, 2024 | 57.76M |
| March 12, 2024 | 60.41M |
| March 11, 2024 | 60.78M |
| March 08, 2024 | 62.67M |
| March 07, 2024 | 63.80M |
| March 06, 2024 | 63.05M |
| March 05, 2024 | 62.29M |
| March 04, 2024 | 61.54M |
| March 01, 2024 | 61.16M |
| February 29, 2024 | 60.28M |
| February 28, 2024 | 63.25M |
| February 27, 2024 | 63.25M |
| February 26, 2024 | 64.00M |
| February 23, 2024 | 62.51M |
| February 22, 2024 | 61.39M |
| February 21, 2024 | 63.25M |
| February 20, 2024 | 65.86M |
| February 16, 2024 | 64.00M |
| February 15, 2024 | 66.23M |
| February 14, 2024 | 67.72M |
| February 13, 2024 | 66.97M |
| February 12, 2024 | 67.35M |
| February 09, 2024 | 71.62M |
| February 08, 2024 | 71.44M |
| February 07, 2024 | 74.42M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
38.32M
Minimum
Mar 17 2023
205.69M
Maximum
Jun 01 2021
94.98M
Average
80.48M
Median
May 03 2019
Market Cap Benchmarks
| NovaBay Pharmaceuticals Inc | 2.558M |
| Palatin Technologies Inc | 30.34M |
| iBio Inc | 6.098M |
| Theriva Biologics Inc | 7.461M |
| Ampio Pharmaceuticals Inc | 0.4088M |
Market Cap Related Metrics
| PE Ratio | 1.092 |
| PS Ratio | 0.4901 |
| Price to Book Value | 0.7347 |
| Price to Free Cash Flow | 1.142 |
| Price | 1.42 |
| Earnings Yield | 91.55% |
| Operating PE Ratio | 0.9452 |
| Normalized PE Ratio | 1.021 |